Spanish regulator authorises phase III trials of Hipra's COVID vaccine

Hipra has said that it anticipates being able to produce 600 million doses in 2022

Phase III is the last round of testing prior to seeking authorisation to market a drug.

Phase III is the last round of testing prior to seeking authorisation to market a drug. | LUKAS BARTH

ReutersPalma01/02/2022 12:20
TW
1

The Spanish medicines agency said on Tuesday it had authorised pharmaceutical firm Hipra to carry out phase III trials of the COVID-19 vaccine it is developing.

Phase III is the last round of testing prior to seeking authorisation to market a drug.

Hipra began phase II trials in November that involved testing the vaccine on 1,000 volunteers across ten hospitals in Spain.

Hipra has said on its website that it anticipates being able to produce 600 million doses in 2022 and double that figure the following year.

Also in News

Golden visa joy for many.

As Spain says adios to Golden Visa, Portugal says come on down!

An Aldi supermarket in Mallorca

The supermarket chain with the greatest savings in Mallorca

Truck stuck in the Mallorca village of Randa.

Truck gets stuck in Mallorca village

The Koru moored in the Bay of Palma.

Amazon boss Jeff Bezos could marry on "Mallorca" yacht

Most viewed
Most Commented